Conclusion

Patients with CRSwNP experience higher rates of asthma and lower rates of URTIs but otherwise do not demonstrate significant socioeconomic, comorbidity, lifestyle or quality of life issues other than for body pain and alcohol consumption. In the future, as endotyping replaces the current phenotypes and means of sampling larger sections of the populations become easier, it will be useful to revisit these findings through further epidemiological study.